Arie Belldegrun, Director at Cougar Biotechnology, Inc. (CGRB), bought 15,000 shares at $18.15 ($275K) on 2007-02-26, disclosed to the SEC on 2007-03-09.
Open-market purchase of $275k CGRB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.15 | 4,000 | $73K | 26.4% |
| 2 | $18.30 | 4,000 | $73K | 26.6% |
| 3 | $18.40 | 5,500 | $101K | 36.8% |
| 4 | $18.85 | 500 | $9K | 3.4% |
| 5 | $18.55 | 1,000 | $19K | 6.7% |
| Total | $18.33 avg | 15,000 |
| $275K |
| 100% |
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |